Outcome of Alzheimer's Drug Evaluation by Advisory Committee and Implications for Eli Lilly

The chapter covers the unanimous approval of an Alzheimer's drug by an advisory committee, detailing its efficacy in clearing brain plaque and the implications for the company's stock and sales.